This inventor holds 2 USPTO granted patents. Top assignee: Whan in Pharm. Co., Ltd.. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Suwon-si, KR (2002)
- Kyunggi-do, KR (2004)
Company Filing History:
Years Active: 2002-2004
Title: Kye Kwan Lee: Innovator in Topical Pharmaceutical Compositions
Introduction
Kye Kwan Lee is a notable inventor based in Gyeonggi, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical preparations. With a total of 2 patents to his name, Lee's work focuses on enhancing the efficacy and safety of treatments for various medical conditions.
Latest Patents
Lee's latest patents include an "Alprostadil alkyl ester-containing composition for external application." This invention relates to a topical preparation that contains alprostadil alkyl ester, an oily vehicle, a skin permeation enhancer, and an anti-irritant agent. His other patent, "Topical preparation of alprostadil for the treatment of erectile dysfunction," describes a composition that boasts an excellent skin permeation rate with minimal irritation. This preparation is created by dissolving alprostadil or a solid dispersion of it, using poloxamer, into a mixture of an oily vehicle, a pyrrolidone, and an anti-irritant agent.
Career Highlights
Kye Kwan Lee is currently associated with Whan in Pharm. Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving patient outcomes through advanced topical formulations.
Collaborations
Lee collaborates with esteemed colleagues, including Dong Soo Lee and Yun Seok Rhee. Their combined expertise contributes to the development of effective pharmaceutical solutions.
Conclusion
Kye Kwan Lee's contributions to the field of topical pharmaceuticals demonstrate his dedication to innovation and patient care. His patents reflect a deep understanding of formulation science and a commitment to improving therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile